Deepro Mukerjee

William J. O'Brien

Jitendra Malik

Kenneth L. Dorsney

Lance Soderstrom

Gordon H. Copland

Joseph M. Janusz

Matthew M. Holub

Alissa M. Pacchioli

Jillian M. Schurr

Bruce R. Genderson

Jessamyn S. Berniker

Stanley E. Fisher

Michael P. Kelly

Daniel M. Silver

James F. Companion

Shaun P. Mahaffy

Alexandra M. Joyce

Frank X. Duff

Sandra K. Law

Alexander S. Zolan

Elise Baumgarten

Jingyuan Luo

Anthony Sheh

Sarahi Uribe

Jeffrey G. Ho

Vanessa Omoroghomwan

Jihad Komis

Post-IPR clash: Merck challenges Mylan's generic Januvia in ANDA lawsuit over a battle-tested `dihydrogenphosphate salt` patent for blockbuster diabetes drugs.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
McCarter & English LLP	L4 A
Michael P. Kelly	L5 A
Daniel M. Silver	L5 A
Alexandra M. Joyce	L3 B
Williams & Connolly LLP	L3 B
Bruce R. Genderson	L5 A
Stanley E. Fisher	L3 E
Jessamyn S. Berniker	L3 E
Shaun P. Mahaffy	L1 B
Alexander S. Zolan	L1 B
Elise Baumgarten	L1 C
Jingyuan Luo	L1 C
Sarahi Uribe	L1 C
Jeffrey G. Ho	L1 C
Jihad Komis	L1 C
Vanessa Omoroghomwan	L1 D
Anthony Sheh	L1 D
Schrader BYRD & Companion PLLCLocal	L1 C
James F. Companion	L1 B
Frank X. Duff	-- -- --
Sandra K. Law	-- -- --

Name	Ratings
Morris James LLPLocal	L4 E
Kenneth L. Dorsney	L4 E
Katten Muchin Rosenman LLP	L3 C
Deepro Mukerjee	L5 E
Jitendra Malik	L4 B
Lance Soderstrom	L4 C
Joseph M. Janusz	L4 D
Matthew M. Holub	L2 C
Alissa M. Pacchioli	L1 B
Jillian M. Schurr	-- -- --
Steptoe & Johnson LLP	L3 E
William J. O'Brien	L4 D
Gordon H. Copland	L2 B

1:19-cv-01489

Merck Sharp & Dohme Corp v. Mylan Pharma Inc